Coloplast to acquire Atos Medical from PAI Partners for $2.5bn.

Coloplast, a medical devices manufacturer, agreed to acquire Atos Medical, a laryngectomy equipment manufacturer and services provider, from PAI Partners, a private equity firm, for $2.5bn. “Atos Medical is an undisputed leader in chronic neck stomas care, and we are well-positioned for long-term growth. Our companies have comparable business models, and the acquisition will enable us to leverage Coloplast’s strengths to serve more people living with a neck stoma even better than today. Coloplast is a world leading medical device company with an impressive track record. I believe our companies are a great match, and I am confident that together we can accelerate our journey to the benefit of our customers worldwide,” Britt Meelby Jensen, Atos Medical CEO.